Insider Trading Activity Hologic, Inc. (NASDAQ:HOLX) – Director Sold 6,902 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Hologic, Inc. (NASDAQ:HOLX)

Elaine Ullian , Director of Hologic, Inc. (NASDAQ:HOLX) reportedly Sold 6,902 shares of the company’s stock at an average price of 40.12 for a total transaction amount of $276,908.24 SEC Form

Insider Trading History For Hologic, Inc. (NASDAQ:HOLX)

On 8/8/2012 Glenn P Muir, CFO, sold 68,750 with an average share price of $19.69 per share and the total transaction amounting to $1,353,687.50.View SEC Filing

On 9/5/2012 Glenn P Muir, CFO, sold 68,750 with an average share price of $19.96 per share and the total transaction amounting to $1,372,250.00.View SEC Filing

On 2/25/2013 Lawrence M Levy, Director, sold 5,000 with an average share price of $22.00 per share and the total transaction amounting to $110,000.00.View SEC Filing

On 6/3/2013 Robert Cascella, CEO, sold 20,000 with an average share price of $20.71 per share and the total transaction amounting to $414,200.00.View SEC Filing

On 6/17/2013 Glenn P Muir, CFO, sold 28,000 with an average share price of $21.42 per share and the total transaction amounting to $599,760.00.View SEC Filing

On 7/1/2013 Robert Cascella, CEO, sold 20,000 with an average share price of $19.55 per share and the total transaction amounting to $391,000.00.View SEC Filing

On 7/15/2013 Glenn P Muir, CFO, sold 28,000 with an average share price of $19.78 per share and the total transaction amounting to $553,840.00.View SEC Filing

Analyst Ratings For Hologic, Inc. (NASDAQ:HOLX)
These are 3 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Hologic, Inc. (NASDAQ:HOLX) is Buy (Score: 2.77) with a consensus target price of $48.62 , a potential (24.56% upside)

Analyst Ratings History For Hologic, Inc. (NASDAQ:HOLX)

On 10/21/2015 Craig Hallum Downgraded rating Buy to Hold with a price target of $42.00 to $37.00
On 10/26/2015 Gabelli Initiated Coverage of rating Buy with a price target of $43.00
On 1/28/2016 J P Morgan Chase & Co Reiterated Rating Buy
On 1/31/2016 William Blair Reiterated Rating Outperform
On 7/28/2016 Morgan Stanley Boost Price Target of rating Equal Weight with a price target of $38.00 to $40.00
On 1/4/2017 Evercore ISI Downgraded rating Buy to Hold with a price target of $42.00
On 3/30/2017 Leerink Swann Reiterated Rating Outperform with a price target of $52.00

Recent Trading Activity for Hologic, Inc. (NASDAQ:HOLX)
Shares of Hologic, Inc. closed the previous trading session at 39.03 down -0.22 -0.56% with 4,007,624 shares trading hands.